Back
Day Range
$4.37
$4.54
52-Week Range
$1.05
$6.02
Volume
1,694,192
50D / 200D Avg
$4.65
/
$3.96
Prev Close
$4.40
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.9 | 0.4 |
| P/B | 4.4 | 2.9 |
| ROE % | -68.5 | 3.8 |
| Net Margin % | -1115.3 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -93.83M
Capital efficient — spends only 7.55% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)17.28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-68.45%
ROIC-31.26%
Net Margin-1115.27%
Op. Margin-1130.65%
Safety
Debt / Equity
0.07
Current Ratio12.23
Interest Coverage-1753.94
Valuation
P/E Ratio
-9.94
P/B Ratio4.39
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.28% | Revenue Growth (3Y) | -20.47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.77M | Net Income (TTM) | -109.00M |
| ROE | -68.45% | ROA | -31.75% |
| Gross Margin | 88.28% | Operating Margin | -1130.65% |
| Net Margin | -1115.27% | Free Cash Flow (TTM) | -93.83M |
| ROIC | -31.26% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 12.23 |
| Interest Coverage | -1753.94 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.94 | P/B Ratio | 4.39 |
| P/S Ratio | 110.81 | PEG Ratio | 2.90 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.08B | Enterprise Value | 781.36M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.77M | 8.33M | 15.45M | 2.50M | 0.0 |
| Net Income | -109.00M | -89.30M | -111.57M | -166.01M | -174.52M |
| EPS (Diluted) | -0.34 | -0.36 | -0.96 | -3.78 | -4.64 |
| Gross Profit | 8.63M | 8.33M | 15.45M | 14,999.0 | 0.0 |
| Operating Income | -110.50M | -91.46M | -72.44M | -126.03M | -173.27M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 343.32M | 160.36M | 172.73M | 126.28M | 213.96M |
| Total Liabilities | 96.38M | 88.84M | 97.79M | 125.33M | 118.57M |
| Shareholders' Equity | 246.94M | 71.53M | 74.94M | 949,000.0 | 95.38M |
| Total Debt | 18.17M | 63.18M | 61.11M | 59.93M | 63.09M |
| Cash & Equivalents | 319.77M | 139.04M | 143.94M | 87.88M | 149.10M |
| Current Assets | 324.65M | 142.13M | 149.87M | 96.42M | 159.60M |
| Current Liabilities | 26.55M | 26.23M | 36.76M | 62.79M | 51.75M |